Dapagliflozin/Metformin

DRUG5 trials

Sponsors

AstraZeneca, Centro Medico Nacional Siglo XXI IMSS, Beni-Suef University

Conditions

Diabetes Mellitus, Type 2HealthyHealthy VolunteersObesity, MorbidPCOPolycystic OvaryPreDiabetes

Phase 1

A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets

CompletedNCT01055691

AstraZenecaHealthy Volunteers

Start: 2010-01-31End: 2010-04-30Updated: 2012-06-01

Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers

CompletedNCT01156246

AstraZenecaHealthy

Start: 2010-06-30End: 2010-08-31Updated: 2012-06-01

Phase 2

Effectiveness of Dapagliflozin for Weight Loss

CompletedNCT03968224

Centro Medico Nacional Siglo XXI IMSSDiabetes Mellitus, Type 2, Obesity, Morbid, PreDiabetes

Start: 2018-08-04End: 2024-07-31Updated: 2025-10-15

Phase 3

of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in PCO

Beni-Suef UniversityPCO

Start: 2022-01-15End: 2023-07-30Target: 200Updated: 2023-05-30

Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome

Not yet recruitingNCT06405178

Beni-Suef UniversityPolycystic Ovary

Start: 2024-09-30End: 2024-12-30Target: 500Updated: 2024-05-08

Related Papers

Efficacy of the treatment with dapagliflozin and metformin compared to metformin monotherapy for weight loss in patients with class III obesity: a randomized controlled trial.

2020-02-142 citations